Patient safety redefined. Digitised, personalised and optimised.
Patient safety redefined. Digitised, personalised and optimised.

Behavioral Science:

Enhancing Our Approach to the Development of Effective Additional Risk Minimization Strategies

April 2024

Behavioural Science image

Axian was delighted to support BMS in convening a group of leading Key Opinion Leaders (KOLs) for a series of discussions. These dialogues focused on the exciting potential of behavioral science to enhance the effectiveness of Additional Risk Minimisation Measures (aRMM).

Our role involved facilitating these discussions and collaborating on the development of a publication summarizing the key insights. This publication aims to spark a wider conversation and encourage stakeholders to explore the possibilities of integrating behavioral science concepts into drug safety practices. We believe that by harnessing the power of behavioral science, we can significantly improve aRMM outcomes, ultimately leading to better outcomes for patients.

Click here to read this article

Contact us

  • The Bradfield Centre
    184 Cambridge Science Park
    Cambridge
    CB4 0GA
    United Kingdom
  • Axian Consulting US Ltd
    6200 Stoneridge Mall Road
    Corporate Commons
    Pleasanton
    CA 94588
    USA